Model
Edge
Alnylam Pharmaceuticals, Inc.
0001511797
Filing type
144
Filing date
Oct 1, 2026
Updated
Oct 2, 2026 ยท 1:45 PM
Copy reference
Filing
144
Notice of Proposed Sale of Securities